Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987;25(3):245-9.
doi: 10.1007/BF00199154.

Enhancement of interleukin-2 release in rats by treatment with bleomycin and adriamycin in vivo

T A Abdul Hamied  1 , J L Turk
Affiliations

Enhancement of interleukin-2 release in rats by treatment with bleomycin and adriamycin in vivo

T A Abdul Hamied et al. Cancer Immunol Immunother. 1987.

Abstract

Spleen cells from rats previously injected with bleomycin (10 mg/kg) or Adriamycin (1 mg/kg) were able to release higher levels of interleukin-2 (IL-2) than cells from untreated animals. The difference in IL-2 release was detected after the cells were exposed to a suboptimal dose of concanavalin A (0.5 micrograms/ml) for 24 h. By cytofluorimetry, these drugs did not change the proportion of W3/25+ (helper) or OX-8+ (suppressor) T-cell subsets. In contrast, the immunosuppressive drug cyclophosphamide inhibited the IL-2 release from spleen cells under the same conditions. It is suggested that some anti-cancer antibiotics may be able to enhance the release of IL-2 while other cytotoxic drugs with more immunosuppressive potential could inhibit the release of this mediator.

PubMed Disclaimer

References

    1. Abdul Hamied TA, Parker D, Turk JL. Potentiation of the release of interleukin-2 by bleomycin. Immunopharmacology. 1986;12:127. - PubMed
    1. Abdul Hamied TA, Parker D, Turk JL (1987) Effects of adriamycin, 4-hydroperoxycyclophosphamide and ASTAZ (INN mafosfamide) on the release of IL-2 and IL-1 in vitro. Int J Immunopharmacol (in press) - PubMed
    1. Brideau RJ, Carter PB, McMaster R, Mason DW, Williams AF. Two subsets of rat T-lymphocytes defined with monoclonal antibodies. Eur J Immunol. 1980;10:609. - PubMed
    1. Cohen S, Salazar D, Wicher J. Adriamycin-induced activation of NK activity may initially involve LAF production. Cancer Immunol Immunother. 1983;15:188. - PMC - PubMed
    1. Ehrke MJ, Cohen SA, Mihich E. Selective effects of adriamycin on murine host defence systems. Immunol Ref. 1982;65:55. - PubMed

Publication types

LinkOut - more resources